Literature DB >> 19687221

Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V.

Francis G Blankenberg1.   

Abstract

Annexin V is a ubiquitous intracellular protein in humans that has a variety of intriguing characteristics, including a nanomolar affinity for the membrane-bound constitutive anionic phospholipid known as phosphatidylserine (PS). PS is selectively expressed on the surface of apoptotic or physiologically stressed cells. As such, radiolabeled forms of annexin V have been used in both animal models and human Phase I and Phase II trials to determine if this tracer can be employed as an early surrogate marker of therapeutic efficacy in NSCLC and non-Hodgkin's lymphoma. Many other pulmonary imaging applications of radiolabeled annexin V are also possible, including the detection and monitoring of active pulmonary inflammation and other pathophysiologic stressors in a variety of diseases. In this article, the salient molecular features of apoptosis (and other forms of cell death) that permits imaging with radiolabeled annexin V will be discussed. The latest results from Phase II imaging trials with NSCLC and non-Hodgkin's lymphoma will be also be detailed. Finally, the potential future application of this tracer for the imaging of other pulmonary pathologies will be outlined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687221      PMCID: PMC2731806          DOI: 10.1513/pats.200901-001AW

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  73 in total

1.  Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death.

Authors:  A K Hammill; J W Uhr; R H Scheuermann
Journal:  Exp Cell Res       Date:  1999-08-25       Impact factor: 3.905

2.  Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine.

Authors:  U Haberkorn; M E Bellemann; G Brix; H Kamencic; I Morr; U Traut; A Altmann; J Doll; J Blatter; R Kinscherf
Journal:  Eur J Nucl Med       Date:  2001-04

3.  Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans.

Authors:  Niels P Riksen; Wim J G Oyen; Bart P Ramakers; Petra H H Van den Broek; Richard Engbersen; Otto C Boerman; Paul Smits; Gerard A Rongen
Journal:  Clin Pharmacol Ther       Date:  2005-07       Impact factor: 6.875

4.  Annexin-V imaging for noninvasive detection of cardiac allograft rejection.

Authors:  J Narula; E R Acio; N Narula; L E Samuels; B Fyfe; D Wood; J M Fitzpatrick; P N Raghunath; J E Tomaszewski; C Kelly; N Steinmetz; A Green; J F Tait; J Leppo; F G Blankenberg; D Jain; H W Strauss
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

Review 5.  Acute lung injury and cell death: how many ways can cells die?

Authors:  Peter S Tang; Marco Mura; Rashmi Seth; Mingyao Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-18       Impact factor: 5.464

6.  The use of 99mTc-recombinant human annexin V imaging for differential diagnosis of aseptic loosening and low-grade infection in hip and knee prostheses.

Authors:  Mordechai Lorberboym; Zeev Feldbrin; David Hendel; Francis G Blankenberg; Pinhas Schachter
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

7.  Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5.

Authors:  H H Boersma; I H Liem; G J Kemerink; P W L Thimister; L Hofstra; L M L Stolk; W L van Heerde; M-T W Pakbiers; D Janssen; A J Beysens; C P M Reutelingsperger; G A K Heidendal
Journal:  Br J Radiol       Date:  2003-08       Impact factor: 3.039

Review 8.  In vivo detection of apoptosis.

Authors:  Francis G Blankenberg
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

9.  Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia.

Authors:  Xian Nan Tang; Qing Wang; Maya A Koike; Danye Cheng; Michael L Goris; Francis G Blankenberg; Midori A Yenari
Journal:  J Nucl Med       Date:  2007-10-17       Impact factor: 10.057

10.  Intraobserver, interobserver, and day-to-day reproducibility of quantitative 99mTc-HYNIC annexin-V imaging in head and neck carcinoma.

Authors:  Hubert Vermeersch; Hamphrey Ham; Sylvie Rottey; Christophe Lahorte; Federica Corsetti; Rudi Dierckx; Neil Steinmetz; Christophe Van de Wiele
Journal:  Cancer Biother Radiopharm       Date:  2004-04       Impact factor: 3.099

View more
  19 in total

1.  The slow cell death response when screening chemotherapeutic agents.

Authors:  Joseph Blois; Adam Smith; Lee Josephson
Journal:  Cancer Chemother Pharmacol       Date:  2010-12-31       Impact factor: 3.333

Review 2.  (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.

Authors:  Tarik Z Belhocine; Francis G Blankenberg; Marina S Kartachova; Larry W Stitt; Jean-Luc Vanderheyden; Frank J P Hoebers; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-16       Impact factor: 9.236

3.  A computationally designed DNA aptamer template with specific binding to phosphatidylserine.

Authors:  Md Ashrafuzzaman; Chih-Yuan Tseng; Janice Kapty; John R Mercer; Jack A Tuszynski
Journal:  Nucleic Acid Ther       Date:  2013-11-26       Impact factor: 5.486

4.  Design of a functional cyclic HSV1-TK reporter and its application to PET imaging of apoptosis.

Authors:  Zhe Wang; Fu Wang; Naoki Hida; Dale O Kiesewetter; Jie Tian; Gang Niu; Xiaoyuan Chen
Journal:  Nat Protoc       Date:  2015-04-30       Impact factor: 13.491

5.  In Vivo Evaluation of Radiofluorinated Caspase-3/7 Inhibitors as Radiotracers for Apoptosis Imaging and Comparison with [18F]ML-10 in a Stroke Model in the Rat.

Authors:  Marie Médoc; Martine Dhilly; Lidia Matesic; Jérôme Toutain; Anwen M Krause-Heuer; Jérôme Delamare; Benjamin H Fraser; Omar Touzani; Louisa Barré; Ivan Greguric; Franck Sobrio
Journal:  Mol Imaging Biol       Date:  2016-02       Impact factor: 3.488

Review 6.  Assessment of tumor response to tyrosine kinase inhibitors.

Authors:  Amanda Lowery; Zhaozhong Han
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

Review 7.  Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care.

Authors:  Lemonitsa H Mammatas; Henk M W Verheul; N Harry Hendrikse; Maqsood Yaqub; Adriaan A Lammertsma; C Willemien Menke-van der Houven van Oordt
Journal:  Cell Oncol (Dordr)       Date:  2014-09-24       Impact factor: 6.730

8.  A cyclic HSV1-TK reporter for real-time PET imaging of apoptosis.

Authors:  Fu Wang; Zhe Wang; Naoki Hida; Dale O Kiesewetter; Ying Ma; Kai Yang; Pengfei Rong; Jimin Liang; Jie Tian; Gang Niu; Xiaoyuan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-20       Impact factor: 11.205

9.  Pharmacokinetics of the phosphatidylserine tracers 99mTc-lactadherin and 99mTc-annexin V in pigs.

Authors:  Runa H Poulsen; Jan T Rasmussen; June Anita Ejlersen; Christian Flø; Lise Falborg; Christian W Heegaard; Michael Rehling
Journal:  EJNMMI Res       Date:  2013-03-09       Impact factor: 3.138

10.  Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis.

Authors:  Gang Niu; Lei Zhu; Don N Ho; Fan Zhang; Haokao Gao; Qimeng Quan; Naoki Hida; Takeaki Ozawa; Gang Liu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2013-02-21       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.